I like your investigation. CCF is one of the national centers in FAP research. I am not surprised you could find research papers from CCF. Even without searching for outside corroboration, it has been well known that selective activation of apoptosis in various cancers like chronic lymphocytic leukemia, low grade lymphomas and other carcinomas have been previously studied and show effective results when combined with other chemotherapy. If my memory serves me, Bcl-2 protein is also been extensively studied. This novel mechanism is going to play an important role in many disease prevention and treatment other than cancer IMHO. I am long at 7 11/16. Any comment appreciated.